2021 American Transplant Congress

June 4-9, 2021

ATC 2021 Virtual Connect is an all-new, completely enhanced virtual meeting experience. The ATC program is built in Eastern Time Zone.

View by Title View Sessions View Topics

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Nanoparticle Mediated Drug Delivery for Lung Transplantation

P. M. Patel¹, S. Jung², C. L. Miller¹, J. M. O¹, T. Costa¹, A. Dehnadi¹, I. Hanekamp¹, X. F. Li², L. Jiang², H. Ichimura², A. Azimzadeh¹, J. C. Madsen³, R. Abdi²
NASH-Related HCC is Associated with Lower Rates of Post-Transplant HCC Recurrence: A Large Database Analysis

P. J. Altshuler, R. Lamm, K. Patel, H. Dang, O. Shaheen, A. P. Shah, J. Glorioso, C. G. Ramirez, A. M. Frank, W. R. Maley, A. S. Bodzin
Native Nephrectomy in Pediatric Kidney Transplant Recipients

D. Yoeli¹, A. Sater¹, A. Peace¹, M. E. Wachs¹, M. Bock², M. A. Adams¹
Natural Sensitization by Pregnancy, Testing Desensitization Strategies in Female NHPs Across Repeat Mismatches

M. Manook, J. Yoon, Z. Fitch, R. Schmitz, A. M. Jackson, J. Kwun, S. Knechtle
Needs of People with Kidney Transplantation During the Covid 19 Pandemic and Its Confinement, and the Role of Communication Technologies Through the “Patient Experience”

I. Revuelta¹, E. Palou², R. Scandurra³, F. Oppenheimer¹, F. Diekmann¹, J. Escarrabill², B. Bayés¹
Neutrophil CEACAM1 Induces Hepatic Autophagy and Shapes Innate-adaptive Immune Response in Liver Transplantation: From Mouse-to-human

H. Hirao¹, H. Kojima¹, K. Kadono¹, K. J. Dery¹, K. Nakamura², D. G. Farmer¹, F. M. Kaldas¹, J. W. Kupiec-Weglinski¹
Neutrophil Extracellular Trap-induced Thrombotic Microangiopathy in Steatotic Mouse Recipients Impacts Liver Transplant Outcomes

H. Hirao, H. Kojima, K. Kadono, K. J. Dery, D. G. Farmer, F. M. Kaldas, J. W. Kupiec-Weglinski
No Benefit of Antithymocyte Globulin in Living Donor Liver Transplant Recipients

N. Wilson, P. Nguyen, G. Saracino, R. Patel, G. Testa, T. Sam
Nomogram of Quantity of Peripheral Cxcr5⁺Cd8⁺ T Cells, Aims to Predict Risk of De Novo Dsa in First-time Kidney Transplant Recipients

J. Zimmerer¹, M. Abdel-Rasoul², G. Bumgardner¹
Non-Alcoholic Fatty Liver Disease in Non-Liver Transplant Patients

R. Claudio¹, C. Conceicao², K. Robichaux², A. Kumar¹, J. Buggs³, N. Kemmer⁴

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z